Foundation for Reproductive Medicine   Report issue

Foundation Phase 2 Phase 3
Founded: New York NY United States

Organization Overview

First Clinical Trial
2007
NCT00419913
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

prasterone (intrarosa) (1 trial)

Drugs in Phase 2 Trials (4)

dehydroepiandrosterone (1 trial)

sargramostim (leukine) (2 trials)

sodium chloride (2 trials)

testosterone (delatestryl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 3)

Infertility, Female (Phase 2)

Menopause, Premature (Phase 2)

Primary Ovarian Insufficiency (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5